In This Article:
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here are three profitable companies to steer clear of and a few better alternatives.
Western Digital (WDC)
Trailing 12-Month GAAP Operating Margin: 20.2%
Founded in 1970 by a Motorola employee, Western Digital (NASDAQ: WDC) is a leading producer of hard disk drives, SSDs and flash memory.
Why Should You Dump WDC?
-
Customers postponed purchases of its products and services this cycle as its revenue declined by 7.9% annually over the last five years
-
Gross margin of 14.5% is below its competitors, leaving less money to invest in areas like marketing and R&D
-
Responsiveness to unforeseen market trends is restricted due to its substandard operating profitability
At $46.24 per share, Western Digital trades at 9.7x forward P/E. Read our free research report to see why you should think twice about including WDC in your portfolio, it’s free.
U-Haul (UHAL)
Trailing 12-Month GAAP Operating Margin: 12.8%
Founded by a husband and wife duo, U-Haul (NYSE:UHAL) is a provider of rental trucks and storage facilities.
Why Is UHAL Risky?
-
Annual sales declines of 1.6% for the past two years show its products and services struggled to connect with the market during this cycle
-
Free cash flow margin dropped by 38.3 percentage points over the last five years, implying the company became more capital intensive as competition picked up
-
Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
U-Haul is trading at $66.70 per share, or 2.3x trailing 12-month price-to-sales. Check out our free in-depth research report to learn more about why UHAL doesn’t pass our bar.
West Pharmaceutical Services (WST)
Trailing 12-Month GAAP Operating Margin: 19.1%
Founded in 1923 and serving as a critical link in the pharmaceutical supply chain, West Pharmaceutical Services (NYSE:WST) manufactures specialized packaging, containment systems, and delivery devices for injectable drugs and healthcare products.
Why Does WST Fall Short?
-
Sales stagnated over the last two years and signal the need for new growth strategies
-
Day-to-day expenses have swelled relative to revenue over the last two years as its adjusted operating margin fell by 5.7 percentage points
-
Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability